Quanterix and Sony DADC Ink Co-Development Deal for SiMoA Consumables
July 22, 2011
Quanterix and Sony DADC Ink Co-Development Deal for SiMoA Consumables
Sony DADC's optical disc technology will provide Quanterix "with a consumable that meets the requirements of high sensitivity diagnostic testing," said a Quanterix official.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Shifting Focus From Dx Development, Quanterix Aims to Launch Commercial SiMoA Instrument in 2013
February 25, 2011 / ProteoMonitor - Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
June 3, 2011 / ProteoMonitor - Quanterix, Gothenberg Researchers Show Potential Link Between Heart Attacks and Alzheimer's Marker
April 15, 2011 / ProteoMonitor - Quanterix Raises $2.5M in Financing Round Targeting $5M
October 15, 2010 / ProteoMonitor - Study Shows Quanterix's Single Molecule Array Assay Measures PSA at Previously Undetectable Levels
June 11, 2010 / ProteoMonitor